Corporate / M&A

Competition

Capital Markets

Financing and Investment Products

Oerlikon

Homburger News

Share-Image Teamplate Deals-and-Cases

On May 6, 2025, OC Oerlikon announced that it has signed a definitive agreement for the divestment of its Barmag textile machinery business for manmade fibers to Rieter at an enterprise value of CHF 850 m with an earn-out of up to CHF 100 m. Upon closing of this transaction, Oerlikon will become a distinct global pure-play surface technology company, serving a broad base of customers in demanding industries – from automotive, aerospace and energy to luxury, medical, defense and semiconductors – with a toolbox of high-tech surface technologies.
The Homburger team is led by Daniel Hasler (Corporate / M&amp;A) and includes Anna Peter, Nicola Togni, Simone Schmid, Oliver Kneubühl, Matthias Müller, Yannick Reber, Fabio Gasser and Raphael Linder (all Corporate / M&amp;A), Dieter Grünblatt and Peter Müller (both Tax), Richard Stäuber and Nicolas Stocker (both Competition), Lorenzo Togni (Capital Markets) as well as Jürg Frick (Financing and Investment Products).

Homburger advises OC Oerlikon on the divestment of its Barmag textile machinery business for manmade fibers to Rieter

Swiss Prime Site

On February 24, 2025, SIX-listed Swiss Prime Site AG (Ticker: SPSN) announced the launch of an accelerated bookbuild offering, which led to the successful placement of 2,926,829 newly issued shares at a placement price of CHF 102.50 each, raising aggregate gross proceeds of approximately CHF 300 m.
The offering was conducted by way of private placements (i) exclusively to professional investors in Switzerland, (ii) outside Switzerland and the United States to qualified investors in reliance on Regulation S under the U.S. Securities Act and other applicable securities laws and (iii) in the United States to qualified institutional buyers in reliance on Rule 144A under the U.S. Securities Act.
The first day of trading of the new shares on the SIX Swiss Exchange is expected to be February 26, 2025. Closing is expected to take place on February 27, 2025. Swiss Prime Site intends to use the net proceeds from the offering for property acquisitions within the next 9-12 months and for general corporate purposes.
Citigroup Global Markets Limited and UBS AG are acting as Joint Global Coordinators and Joint Bookrunners in connection with the offering.
Homburger advises Swiss Prime Site AG on all aspects of the transaction. The Homburger team is led by Daniel Hasler (Corporate / M&amp;A, Capital Markets) and Lorenzo Togni (Capital Markets) and includes Olivier Baum (Capital Markets) and Yannick Reber (Corporate / M&amp;A). Stefan Oesterhelt (Tax) provides tax advice.

Homburger advises Swiss Prime Site AG on the placement of 2.9 m shares via an accelerated bookbuild offering, raising gross proceeds of CHF 300 m

IP / IT

Employment and Executive Compensation

Bioversys

20250129_Bioversys

On January 29, 2025, BioVersys AG, a clinical-stage biopharmaceutical company developing and commercializing novel antibacterial products for life-threatening infections domiciled in Basel, Switzerland, announced the launch of its Initial Public Offering (IPO) on SIX Swiss Exchange, the publication of the offer price and the start of the bookbuilding process. The IPO comprises a primary offering targeting gross proceeds of CHF 80 m (including an over-allotment option targeting gross proceeds of CHF 5 m). The implied market capitalization of the company, assuming all offered shares are sold in the IPO and the over-allotment option is exercised in full, is approximately CHF 212.9 m. The first day of trading is expected to be February 7, 2025.
BioVersys focuses on identifying, developing and commercializing novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The Company&#8217;s most advanced R&amp;D programs address nosocomial pneumonia and blood stream infections caused by Acinetobacter baumannii (BV100, phase 3-ready) and tuberculosis (alpibectir, phase 2a). In addition to its domicile in the biotech hub in Basel, Switzerland, BioVersys has operations in in Lille, France, Delaware, United States and Guangzhou, China.
Citigroup Global Markets Limited, UBS AG and Stifel Europe AG are acting as Joint Global Coordinators and Joint Bookrunners on the IPO, Mirabaud &amp; Cie SA and Octavian AG as Selling Agents.
Homburger is advising BioVersys on all aspects of the IPO as lead counsel. The Homburger team is co-led by Dieter Gericke and Lorenzo Togni and includes Thierry Burckhardt, Magda Aref, Simone Schmid, Raphael Linder, Harun Cetin and Leander Etter (all Corporate / M&amp;A and Capital Markets). Luca Dal Molin and Kristina Martinovic (both IP / IT) are providing intellectual property advice, Jeremy Reichlin (Employment and Executive Compensation) is providing employment and executive compensation advice, and Reto Heuberger and Philippe Weber (both Tax) are providing tax advice.

Lorenzo
Togni

Homburger advises OC Oerlikon on the divestment of its Barmag textile machinery business for manmade fibers to Rieter

Homburger advises Swiss Prime Site AG on the placement of 2.9 m shares via an accelerated bookbuild offering, raising gross proceeds of CHF 300 m

Homburger advises BioVersys AG on its IPO on SIX Swiss Exchange

Indicative Timeline for an IPO (Switzerland)

Indicative Timeline for an IPO (Switzerland)

Moving the Goalposts between Launch and Pricing oder Der Prospektnachtrag beim IPO unter bisherigem und zukünftigem Recht

Join the Team

Lorenzo Togni

Career

Languages

Bar Registration

Teams

LorenzoTogni

Homburger advises OC Oerlikon on the divestment of its Barmag textile machinery business for manmade fibers to Rieter

Homburger advises Swiss Prime Site AG on the placement of 2.9 m shares via an accelerated bookbuild offering, raising gross proceeds of CHF 300 m

Homburger advises BioVersys AG on its IPO on SIX Swiss Exchange

Indicative Timeline for an IPO (Switzerland)

Indicative Timeline for an IPO (Switzerland)

Moving the Goalposts between Launch and Pricing oder Der Prospektnachtrag beim IPO unter bisherigem und zukünftigem Recht

Join the Team

Lorenzo Togni

Career

Languages

Bar Registration

Teams

Lorenzo
Togni